Voxel S.A. (VOX.WA)
PLN 138.0
(-0.29%)
PLN 138.0
(-0.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 233.62 Million PLN | 4.56% |
| 2022 | 223.43 Million PLN | -15.53% |
| 2021 | 264.52 Million PLN | 2.91% |
| 2020 | 257.05 Million PLN | 41.13% |
| 2019 | 182.13 Million PLN | 30.96% |
| 2018 | 139.07 Million PLN | 28.07% |
| 2017 | 108.59 Million PLN | 1.74% |
| 2016 | 106.73 Million PLN | 5.68% |
| 2015 | 101 Million PLN | -9.41% |
| 2014 | 111.48 Million PLN | 4.67% |
| 2013 | 106.51 Million PLN | 25.63% |
| 2012 | 84.78 Million PLN | -29.29% |
| 2011 | 119.9 Million PLN | 20.05% |
| 2010 | 99.88 Million PLN | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 222.62 Million PLN | -4.71% |
| 2024 Q2 | 248.71 Million PLN | 11.72% |
| 2023 Q3 | 246.85 Million PLN | 4.41% |
| 2023 Q4 | 233.62 Million PLN | -5.36% |
| 2023 FY | 233.62 Million PLN | 4.56% |
| 2023 Q1 | 223.81 Million PLN | 0.17% |
| 2023 Q2 | 236.42 Million PLN | 5.64% |
| 2022 Q4 | 223.43 Million PLN | -7.63% |
| 2022 Q2 | 265.13 Million PLN | 3.99% |
| 2022 FY | 223.43 Million PLN | -15.53% |
| 2022 Q1 | 254.95 Million PLN | -3.62% |
| 2022 Q3 | 241.88 Million PLN | -8.77% |
| 2021 Q1 | 241.02 Million PLN | -6.23% |
| 2021 Q2 | 307.86 Million PLN | 27.73% |
| 2021 Q3 | 258.99 Million PLN | -15.87% |
| 2021 Q4 | 264.52 Million PLN | 2.13% |
| 2021 FY | 264.52 Million PLN | 2.91% |
| 2020 Q1 | 209.51 Million PLN | 15.03% |
| 2020 Q2 | 222.02 Million PLN | 5.97% |
| 2020 Q3 | 253.71 Million PLN | 14.27% |
| 2020 Q4 | 257.05 Million PLN | 1.32% |
| 2020 FY | 257.05 Million PLN | 41.13% |
| 2019 Q4 | 182.13 Million PLN | 9.54% |
| 2019 Q3 | 166.27 Million PLN | -1.73% |
| 2019 Q2 | 169.19 Million PLN | 8.76% |
| 2019 Q1 | 155.56 Million PLN | 11.86% |
| 2019 FY | 182.13 Million PLN | 30.96% |
| 2018 Q3 | 109.53 Million PLN | 12.54% |
| 2018 Q2 | 97.32 Million PLN | 3.76% |
| 2018 Q1 | 93.79 Million PLN | -13.63% |
| 2018 FY | 139.07 Million PLN | 28.07% |
| 2018 Q4 | 139.07 Million PLN | 26.97% |
| 2017 Q1 | 106.2 Million PLN | -0.49% |
| 2017 Q2 | 108.57 Million PLN | 2.23% |
| 2017 Q3 | 103.1 Million PLN | -5.04% |
| 2017 Q4 | 108.59 Million PLN | 5.32% |
| 2017 FY | 108.59 Million PLN | 1.74% |
| 2016 Q1 | 98.23 Million PLN | -2.74% |
| 2016 FY | 106.73 Million PLN | 5.68% |
| 2016 Q4 | 106.73 Million PLN | 6.46% |
| 2016 Q3 | 100.25 Million PLN | 0.87% |
| 2016 Q2 | 99.39 Million PLN | 1.18% |
| 2015 Q2 | 101.74 Million PLN | -2.71% |
| 2015 Q1 | 104.57 Million PLN | -6.2% |
| 2015 FY | 101 Million PLN | -9.41% |
| 2015 Q4 | 101 Million PLN | 4.22% |
| 2015 Q3 | 96.9 Million PLN | -4.75% |
| 2014 Q2 | 106.95 Million PLN | 2.4% |
| 2014 FY | 111.48 Million PLN | 4.67% |
| 2014 Q1 | 104.44 Million PLN | -1.94% |
| 2014 Q4 | 111.48 Million PLN | 2.52% |
| 2014 Q3 | 108.74 Million PLN | 1.68% |
| 2013 Q2 | 108.98 Million PLN | -5.37% |
| 2013 Q3 | 105.83 Million PLN | -2.89% |
| 2013 Q4 | 106.51 Million PLN | 0.64% |
| 2013 Q1 | 115.17 Million PLN | 35.85% |
| 2013 FY | 106.51 Million PLN | 25.63% |
| 2012 Q3 | 103.03 Million PLN | 0.0% |
| 2012 FY | 84.78 Million PLN | -29.29% |
| 2012 Q4 | 84.78 Million PLN | -17.72% |
| 2011 FY | 119.9 Million PLN | 20.05% |
| 2011 Q4 | 119.9 Million PLN | 0.0% |
| 2010 FY | 99.88 Million PLN | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BioMaxima S.A. | 19.93 Million PLN | -1071.76% |
| Scope Fluidics S.A. | 16.81 Million PLN | -1289.471% |
| Selvita S.A. | 309.18 Million PLN | 24.439% |